Nimbus Therapeutics - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $87,138.43 -1.48%
Ethereum $3,171.57 -4.60%
BNB $604.82 -7.03%
Optimism $1.54 -13.23%
Arbitrum $0.59 -11.30%
Solana $204.86 -6.41%
Polygon $0.37 -10.92%
Cosmos $4.96 -10.24%
Avalanche $32.01 -9.01%

Bitcoin $87,138.43 -1.48%
Ethereum $3,171.57 -4.60%
BNB $604.82 -7.03%
Optimism $1.54 -13.23%
Arbitrum $0.59 -11.30%
Solana $204.86 -6.41%
Polygon $0.37 -10.92%
Cosmos $4.96 -10.24%
Avalanche $32.01 -9.01%

Nimbus Therapeutics

company

Investors

Number of Lead Investors

Number of Investors

7

17

Nimbus Therapeutics is funded by 17 investors. Access Biotechnology and Atlas Venture are the most recent investors.

Investor Name	Lead Investor	Funding Round
Access Biotechnology	-	Series Unknown
Atlas Venture	-	Series Unknown
Bain Capital Life Sciences	-	Series Unknown
Bill Gates	-	Series Unknown
Biotechnology Value Fund	-	Series Unknown
Lightstone Ventures	-	Series Unknown
Pfizer Venture Investments	-	Series Unknown
RA Capital Management	-	Series Unknown
SR One	-	Series Unknown
SV Health Investors	-	Series Unknown
Commodore Capital	-	Series Unknown
Logos Capital	-	Series Unknown
Surveyor Capital	-	Series Unknown
BVF Partners	-	Series Unknown
Lilly Ventures	-	Series C
Schrödinger	-	Series C
Richard Friesner	-	Seed